Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder
Sponsor: Severance Hospital
Summary
The purpose of this study is to determine whether pharmaco(epi)genetic study predict selective serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance of the drug effect until 4 months(16 weeks), 6 months, and 1 year after administration of SSRIs.
Official title: Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive
Key Details
Gender
All
Age Range
19 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2013-01-01
Completion Date
2030-12-31
Last Updated
2024-12-27
Healthy Volunteers
No
Conditions
Interventions
SSRIs
usual dose SSRI for obsessive-compulsive disorder, i.e. fluoxetine 40\~80 mg dose equivalents
Locations (1)
Yonsei Univ. Health System Severance Hospital
Seoul, South Korea